Skip to content

Insider · CIK 0001224966

GLASS J KENNETH

Reports to the SEC for 3 companies · MEMPHIS, TN

Transactions

50

Companies

3

Filings

18

CIK

0001224966

Forms 4 and 5

Insider transactions

50 trades
DateCompanyValue
2018-05-10Oncternal Therapeutics, Inc.Director Stock Option (Right to Buy)A Award—
2017-05-12Oncternal Therapeutics, Inc.Director Stock Option (Right to Buy)A Award—
2016-05-05Oncternal Therapeutics, Inc.Director Stock Option (Right to Buy)A Award+$35.5K
2016-03-01Oncternal Therapeutics, Inc.P Purchase+$26.4K
2015-12-24Oncternal Therapeutics, Inc.P Purchase+$79
2015-12-23Oncternal Therapeutics, Inc.P Purchase+$474
2015-12-22Oncternal Therapeutics, Inc.P Purchase+$1,019.46
2015-12-21Oncternal Therapeutics, Inc.P Purchase+$31.1K
2015-05-19Oncternal Therapeutics, Inc.P Purchase+$30.6K
2015-05-07Oncternal Therapeutics, Inc.Director Stock Option (Right to Buy)A Award+$76K
2015-04-22Oncternal Therapeutics, Inc.P Purchase+$7,200
2015-04-21Oncternal Therapeutics, Inc.P Purchase+$5,435.76
2015-04-20Oncternal Therapeutics, Inc.P Purchase+$2,845.44
2015-04-15Oncternal Therapeutics, Inc.P Purchase+$2,376
2015-04-10Oncternal Therapeutics, Inc.P Purchase+$11K
2013-05-03Oncternal Therapeutics, Inc.Director Stock Option (Right to Buy)A Award+$97K
2012-08-27Oncternal Therapeutics, Inc.P Purchase+$37.6K
2012-05-04Oncternal Therapeutics, Inc.Director Stock Option (Right to Buy)A Award+$45.3K
2011-06-06Oncternal Therapeutics, Inc.P Purchase+$101K
2011-05-06Oncternal Therapeutics, Inc.Director Stock Option (Right to Buy)A Award+$81K
2011-04-15Oncternal Therapeutics, Inc.P Purchase+$57.4K
2010-06-22Oncternal Therapeutics, Inc.P Purchase+$20.3K
2010-04-30Oncternal Therapeutics, Inc.Director Stock Option (Right to Buy)A Award+$32.8K
2009-05-07Oncternal Therapeutics, Inc.Director Stock Option (Right to Buy)A Award+$95.3K
2009-02-12Oncternal Therapeutics, Inc.P Purchase+$51.4K
2009-01-28Oncternal Therapeutics, Inc.P Purchase+$53.2K
2007-12-31Oncternal Therapeutics, Inc.A Award+$3,000.011
2007-10-01Oncternal Therapeutics, Inc.A Award+$5,000.076
2007-09-30Oncternal Therapeutics, Inc.A Award+$2,250.059
2007-07-01Oncternal Therapeutics, Inc.A Award+$4,999.958
2007-05-07Oncternal Therapeutics, Inc.A Award+$2,375.24
2007-05-07Oncternal Therapeutics, Inc.A Award+$21.6K
2007-05-07Oncternal Therapeutics, Inc.A Award+$5,982
2007-05-07Oncternal Therapeutics, Inc.A Award+$1,993
2007-05-07Oncternal Therapeutics, Inc.A Award+$15.9K
2007-05-07Oncternal Therapeutics, Inc.A Award+$39.4K
2007-05-07Oncternal Therapeutics, Inc.A Award+$70.1K
2007-05-07Oncternal Therapeutics, Inc.A Award+$35.4K
2007-05-07Oncternal Therapeutics, Inc.A Award+$2,405.48
2007-05-07Oncternal Therapeutics, Inc.A Award+$3,974
2007-02-20FHNFIRST HORIZON CORPS Sale−$2.17M
2007-02-16FHNFIRST HORIZON CORPM Exercise/Conversion+$1.02M
2007-02-16FHNFIRST HORIZON CORP · Stock Options (Right to buy)M Exercise/Conversion−$1.02M
2007-01-01Oncternal Therapeutics, Inc.A Award+$5,000.017
2006-10-01Oncternal Therapeutics, Inc.A Award+$5,000.041
2006-07-01Oncternal Therapeutics, Inc.A Award+$4,999.995
2006-04-27Oncternal Therapeutics, Inc.Director Stock Option (Right to Buy)A Award+$80.6K
2006-04-01Oncternal Therapeutics, Inc.A Award+$5,000.05
2006-01-01Oncternal Therapeutics, Inc.A Award+$5,000.033
2005-09-30Oncternal Therapeutics, Inc.A Award+$5,000.029

Recent filings

18

Companies

3

Address

3 N. DUNLAP STREET 3RD FLOOR

MEMPHIS, TN, 38163